131 related articles for article (PubMed ID: 9413511)
21. Evaluation of serological diagnosis of Borna disease virus infection using recombinant proteins in experimentally infected rats.
Ogino M; Yoshimatsu K; Tsujimura K; Mizutani T; Arikawa J; Takashima I
J Vet Med Sci; 1998 Apr; 60(4):531-4. PubMed ID: 9592731
[TBL] [Abstract][Full Text] [Related]
22. Neutralizing antibodies in persistent borna disease virus infection: prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis.
Furrer E; Bilzer T; Stitz L; Planz O
J Virol; 2001 Jan; 75(2):943-51. PubMed ID: 11134307
[TBL] [Abstract][Full Text] [Related]
23. Analysis of virus-specific RNA species and proteins in Freon-113 preparations of the Borna disease virus.
Richt JA; Clements JE; Herzog S; Pyper J; Wahn K; Becht H
Med Microbiol Immunol; 1993 Nov; 182(5):271-80. PubMed ID: 8283962
[TBL] [Abstract][Full Text] [Related]
24. Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.
Perez M; Clemente R; Robison CS; Jeetendra E; Jayakar HR; Whitt MA; de la Torre JC
J Virol; 2007 Jun; 81(11):5527-36. PubMed ID: 17376911
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and functional analysis of the Borna disease virus G protein.
Schneider PA; Hatalski CG; Lewis AJ; Lipkin WI
J Virol; 1997 Jan; 71(1):331-6. PubMed ID: 8985354
[TBL] [Abstract][Full Text] [Related]
26. Reverse transcription-nested polymerase chain reaction for detecting p40 RNA of Borna disease virus, without risk of plasmid contamination.
Mizutani T; Nishino Y; Kariwa H; Takashima I
J Vet Med Sci; 1999 Jan; 61(1):77-80. PubMed ID: 10027171
[TBL] [Abstract][Full Text] [Related]
27. Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization.
Carbone KM; Moench TR; Lipkin WI
J Neuropathol Exp Neurol; 1991 May; 50(3):205-14. PubMed ID: 2022964
[TBL] [Abstract][Full Text] [Related]
28. Detection of a novel Borna disease virus-encoded 10 kDa protein in infected cells and tissues.
Wehner T; Ruppert A; Herden C; Frese K; Becht H; Richt JA
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2459-66. PubMed ID: 9349465
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of the antiviral action of 1-beta-D-arabinofuranosylcytosine on Borna disease virus.
Volmer R; Bajramovic JJ; Schneider U; Ufano S; Pochet S; Gonzalez-Dunia D
J Virol; 2005 Apr; 79(7):4514-8. PubMed ID: 15767452
[TBL] [Abstract][Full Text] [Related]
30. Identification of the Borna disease virus (BDV) proteins required for the formation of BDV-like particles.
Perez M; de la Torre JC
J Gen Virol; 2005 Jul; 86(Pt 7):1891-1895. PubMed ID: 15958667
[TBL] [Abstract][Full Text] [Related]
31. Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity.
Chase G; Mayer D; Hildebrand A; Frank R; Hayashi Y; Tomonaga K; Schwemmle M
J Virol; 2007 Jan; 81(2):743-9. PubMed ID: 17079312
[TBL] [Abstract][Full Text] [Related]
32. Ribavirin inhibits Borna disease virus proliferation and fatal neurological diseases in neonatally infected gerbils.
Lee BJ; Matsunaga H; Ikuta K; Tomonaga K
Antiviral Res; 2008 Dec; 80(3):380-4. PubMed ID: 18778737
[TBL] [Abstract][Full Text] [Related]
33. A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases.
VandeWoude S; Richt JA; Zink MC; Rott R; Narayan O; Clements JE
Science; 1990 Nov; 250(4985):1278-81. PubMed ID: 2244211
[TBL] [Abstract][Full Text] [Related]
34. Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells.
Staeheli P; Sentandreu M; Pagenstecher A; Hausmann J
J Virol; 2001 Sep; 75(17):8216-23. PubMed ID: 11483767
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes: decreased susceptibility to homotypic infection and disease.
Rauer M; Götz J; Schuppli D; Staeheli P; Hausmann J
J Virol; 2004 Apr; 78(7):3621-32. PubMed ID: 15016883
[TBL] [Abstract][Full Text] [Related]
36. Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro.
Bode L; Dietrich DE; Spannhuth CW; Ludwig H
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336901
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of Borna virus RNAs.
Pyper JM; Brown L; Clements JE
Arch Virol Suppl; 1994; 9():417-27. PubMed ID: 8032272
[TBL] [Abstract][Full Text] [Related]
38. A methionine-rich domain mediates CRM1-dependent nuclear export activity of Borna disease virus phosphoprotein.
Yanai H; Kobayashi T; Hayashi Y; Watanabe Y; Ohtaki N; Zhang G; de la Torre JC; Ikuta K; Tomonaga K
J Virol; 2006 Feb; 80(3):1121-9. PubMed ID: 16414989
[TBL] [Abstract][Full Text] [Related]
39. Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial.
Dietrich DE; Bode L; Spannhuth CW; Lau T; Huber TJ; Brodhun B; Ludwig H; Emrich HM
Bipolar Disord; 2000 Mar; 2(1):65-70. PubMed ID: 11254023
[TBL] [Abstract][Full Text] [Related]
40. Adaptation of Borna disease virus to new host species attributed to altered regulation of viral polymerase activity.
Ackermann A; Staeheli P; Schneider U
J Virol; 2007 Aug; 81(15):7933-40. PubMed ID: 17522214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
